3 B), while in advanced stages, a trend towards shorter OS for patients with high ActA plasma levels did not reach statistical significance (median OS 7.33 vs 23.23 months, HR 0.462, 95 % CI 0.186–1.141, p = 0.065, Fig. 3 C).
← all excerpts
High circulating activin A plasma levels are associated with tumour stage and poor survival in treatment-naive lung squamous cell cancer patients.
1
0.0650
0.0650